Cause UK specialise in supporting ethical businesses, good causes, festivals and the arts with award winning public relations services.
Genesis Research Trust Cause UK is working with Genesis Research Trust to launch a media campaign this July with the charity’s Chairman, Professor Lord Winston, for the 40th anniversary of…
Genesis Research Trust
Cause UK is working with Genesis Research Trust to launch a media campaign this July with the charity’s Chairman, Professor Lord Winston, for the 40th anniversary of the birth of Louise Brown – the world’s first IVF baby.
The media work is to highlight concerns around the psychological impact of IVF, as well as the increasing commercialisation of treatment, exploring healthier ways to tackle the root causes of infertility.
Clair Challenor-Chadwick said, “As a triplet born in 1973 to parents who had fertility treatment, it is fascinating to see how IVF has developed within our own lifetime. Genesis Research Trust does ground breaking work in the field, and it’s an honour to be working with them.”
Genesis Research Trust is a charitable organisation seeking better health for women and babies. It has raised £13 million to build and equip the most advanced research centre in Europe at Imperial College in London for Reproductive and Developmental Biology. Donate here.
See full press release below.
Professor Lord Winston, Chairman of Genesis Research Trust, has said the anniversary of the birth of the world’s first IVF baby, Louise Brown, should mark a ‘moment for most serious reflection’ warning of failures around regulating the high cost of experimental treatments.
Professor Lord Winston said: “The fortieth anniversary of the birth of Louise Brown, the world’s first IVF baby, is a time to celebrate the great happiness of millions of couples. But this achievement of Patrick Steptoe and Robert Edwards, and many other pioneers, is also a moment for most serious reflection.”
Forty years on, the success of IVF is far lower than people imagine. In the UK, less than 20% of IVF cycles result in live births. In Australia, success is even lower at 18.1%. In the USA, 26% of cycles result in a baby, but one third are multiple births, risking death, disability, brain damage and great costs in premature care.
Despite celebrating achievements and breakthroughs in IVF, Professor Lord Winston cites the commercialisation of treatment has resulted in failures by its regulatory body.
He said: “The UK multiple birth rate fell below 10% because the Human Fertilisation and Embryology Authority (HFEA) made the excellent decision to persuade doctors to limit the embryos transferred, a policy first advocated nearly 30 years ago by the Genesis Research Trust in 1986.”
“But the HFEA has failed elsewhere. IVF became a massive private industry because the NHS did not provide more and better treatment. Moreover, some NHS clinics are not averse to failure because it is recognised that once patients have failed treatment and their NHS funding is consumed, the clinic can welcome them as private patients.
“The HFEA must do more in making stronger recommendations about IVF charges. For example, many experimental treatments during private IVF are extremely costly and are given without adequate scientific evidence of their efficacy. Patients should not have to pay these costs.”
Genesis Research Trust, the charity seeking better health for women and babies, raised £13 million to build and equip the most advanced research centre in Europe for Reproductive and Developmental Biology. It also financed many innovations in IVF treatment and supported the first NHS clinic, based at Hammersmith Hospital, Imperial College.
Julia Margo, CEO of Genesis Research Trust, said: “There’s a growing concern around the psychological and financial fall-out for women and their families who undergo cycles of IVF and can experience a devastating ordeal because of false hopes with the misconception that IVF offers a miracle solution to infertility.”
Lord Winston, a Professor of Science and Society and Emeritus Professor of Fertility Studies at Imperial College London, said more research was urgently needed.
He said: “The financial rewards of private IVF are so great that it is difficult now to attract good academic staff. Inevitably, young doctors finishing training seek the most lucrative employment. It is clear that the success of IVF could be improved substantially, but without research – such as before Louise Brown’s birth – IVF will continue to cause great distress. More basic research and randomised controlled trials of experimental treatments are urgently needed. The HFEA has not helped. Indeed, its bureaucracy, inspection process, its charges and the process it uses to review research projects inhibit research.”
ENDS
Notes to Editors Lord Winston is available for interview with broadcast media the week commencing 9th July 2018.
For media enquiries contact clair@causeuk.com, 07531948014
About the Genesis Research Trust Founded in 1945, Genesis Research Trust, based at Imperial College London, is the largest collaboration of reproductive health researchers in the UK. The Genesis Research Trust charity registration number is 292518 Go to www.genesisresearchtrust.com for more information
Photographer credit: Murray Sanders, Daily Mail